Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode.
Segura AG, Mezquida G, Martínez-Pinteño A, Gassó P, Rodriguez N, Moreno-Izco L, Amoretti S, Bioque M, Lobo A, González-Pinto A, García-Alcon A, Roldán-Bejarano A, Vieta E, de la Serna E, Toll A, Cuesta MJ, Mas S, Bernardo M; PEPs Group. Segura AG, et al. Among authors: lobo a. Psychol Med. 2023 Jul;53(10):4634-4647. doi: 10.1017/S0033291722001544. Epub 2022 Jun 9. Psychol Med. 2023. PMID: 35678455 Free PMC article.
Peripheral endocannabinoid system dysregulation in first-episode psychosis.
Bioque M, García-Bueno B, Macdowell KS, Meseguer A, Saiz PA, Parellada M, Gonzalez-Pinto A, Rodriguez-Jimenez R, Lobo A, Leza JC, Bernardo M; FLAMM-PEPs study—Centro de Investigacio´n Biome´dica en Red de Salud Mental. Bioque M, et al. Among authors: lobo a. Neuropsychopharmacology. 2013 Dec;38(13):2568-77. doi: 10.1038/npp.2013.165. Epub 2013 Jul 4. Neuropsychopharmacology. 2013. PMID: 23822951 Free PMC article.
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, de la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M; PEPs Group. Cuesta MJ, et al. Among authors: lobo a. Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26. Schizophr Res. 2015. PMID: 25819935
BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.
Martinez-Cengotitabengoa M, MacDowell KS, Alberich S, Diaz FJ, Garcia-Bueno B, Rodriguez-Jimenez R, Bioque M, Berrocoso E, Parellada M, Lobo A, Saiz PA, Matute C, Bernardo M, Gonzalez-Pinto A, Leza JC; FLAMM-PEPs. Martinez-Cengotitabengoa M, et al. Among authors: lobo a. Schizophr Bull. 2016 Jan;42(1):142-51. doi: 10.1093/schbul/sbv078. Epub 2015 Jun 30. Schizophr Bull. 2016. PMID: 26130821 Free PMC article.
Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis.
Pina-Camacho L, Del Rey-Mejías Á, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, Lacalle-Aurioles M, Cuesta MJ, Saiz-Ruiz J, Bernardo M, Parellada M; PEPs Group. Pina-Camacho L, et al. Among authors: lobo a. Schizophr Bull. 2016 Mar;42(2):344-57. doi: 10.1093/schbul/sbv128. Epub 2015 Sep 14. Schizophr Bull. 2016. PMID: 26371339 Free PMC article.
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP. Bioque M, et al. Among authors: lobo a. Int J Neuropsychopharmacol. 2016 Mar 31;19(4):pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr. Int J Neuropsychopharmacol. 2016. PMID: 26506856 Free PMC article.
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.
Bioque M, Cabrera B, García-Bueno B, Mac-Dowell KS, Torrent C, Saiz PA, Parellada M, González-Pinto A, Lobo A, Leza JC, Bernardo M; FLAMM-PEPs Study - Centro de Investigación Biomédica en Red de Salud Mental. Bioque M, et al. Among authors: lobo a. J Psychiatr Res. 2016 Apr;75:14-21. doi: 10.1016/j.jpsychires.2016.01.002. Epub 2016 Jan 6. J Psychiatr Res. 2016. PMID: 26783729
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S, Gassó P, Lafuente A, Bioque M, Lobo A, Gonzàlez-Pinto A, Olmeda MS, Corripio I, Llerena A, Cabrera B, Saiz-Ruiz J, Bernardo M; PEPs GROUP. Mas S, et al. Among authors: lobo a. Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7. Pharmacogenomics J. 2016. PMID: 27272046
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.
González-Pinto A, González-Ortega I, Alberich S, Ruiz de Azúa S, Bernardo M, Bioque M, Cabrera B, Corripio I, Arango C, Lobo A, Sánchez-Torres AM, Cuesta MJ; PEPs Group. González-Pinto A, et al. Among authors: lobo a. PLoS One. 2016 Aug 11;11(8):e0160949. doi: 10.1371/journal.pone.0160949. eCollection 2016. PLoS One. 2016. PMID: 27513670 Free PMC article.
880 results